Company Overview

Company name: ReaGenics
Description: Developer of a cannabinoid profiles to produce controlled and customized cannabis biomass. The company uses the mass-scale multiplication of cannabis plant cells under in-vitro laboratory conditions in which the company’s PCBR removes environmental complications by eliminating the need to grow whole plants, enabling clients to obtain bulk-scale, high-quality, botanically derived cannabinoids.
Year founded: 2018
Parent company:
Industry: Healthcare | Group: | Code:
City: Beit Shemesh
Country: Israel
Region: Middle East

Financial Highlights

Start up capital raised (USD Million):
Business status: Generating Revenue
Ownership: Privately Held (backing)
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Enterprise value:
Earnings before interest, tax, depreciation and amortization (EBITDA):
Fiscal period:
Financing Status: The company joined iCAN on an undisclosed date.
Number of active investors:
Profile last updated: 19-Oct-2019
Last known valuation:
Last known valuation date: